KRT5 and invasive breast carcinoma: Therefore, the research was broadened to cover a larger range of invasive breast carcinoma of no special type cases (14), analyzing the associations with selected clinicopathological data and the well-known immunohistochemical markers, Ki-67 (15) and basal marker, cytokeratin 5/6 (CK 5/6).